Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Strategies to improve liver regeneration

Published byMarcia Nash Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 3 Strategies to improve liver regeneration"— Presentation transcript:

1 Figure 3 Strategies to improve liver regeneration
Figure 3 | Strategies to improve liver regeneration. Strategies to improve liver regeneration include the removal of injurious agents, the promotion of fibrosis resolution and the direct stimulation of hepatocyte proliferation. The balance between these two sets of processes is key in determining the clinical outcome. GCSF, granulocyte colony-stimulating factor; HSC, hepatic stellate cell; MSC, mesenchymal stromal cell; T3, thyroid hormone. Forbes, S. J. & Newsome, P. N. (2016) Liver regeneration — mechanisms and models to clinical application Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Download ppt "Figure 3 Strategies to improve liver regeneration"

Similar presentations

What exactly is it that we are responsible for knowing from this website? There are many different photos of many different specific types of tumors...which.

What exactly is it that we are responsible for knowing from this website? There are many different photos of many different specific types of tumors...which.
Figure 1 Proposed risk stratification for patients with NAFLD

Figure 1 Proposed risk stratification for patients with NAFLD
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 Extracellular stimuli to HSC activation

Figure 3 Extracellular stimuli to HSC activation
Figure 1 Contribution of the gut microbiota

Figure 1 Contribution of the gut microbiota
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 7 Treatment algorithm for perianal fistulizing disease

Figure 7 Treatment algorithm for perianal fistulizing disease
Figure 6 Injection of mesenchymal stem cells in perianal fistulas

Figure 6 Injection of mesenchymal stem cells in perianal fistulas
Figure 7 Management algorithm for patients with ACLF

Figure 7 Management algorithm for patients with ACLF
Figure 5 Lipid droplet consumption

Figure 5 Lipid droplet consumption
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 The microbiome–gut–brain axis

Figure 2 The microbiome–gut–brain axis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Immune mechanisms in liver homeostasis

Figure 1 Immune mechanisms in liver homeostasis
Figure 2 Signalling molecules and pathways involved in HSC activation

Figure 2 Signalling molecules and pathways involved in HSC activation
Figure 1 Biosimilar development process

Figure 1 Biosimilar development process
Figure 2 The concept of the hepatic reserve and ACLF

Figure 2 The concept of the hepatic reserve and ACLF
Figure 4 Giant lipid droplet formation

Figure 4 Giant lipid droplet formation
Figure 4 Tumour-induced neutrophil extracellular trap

Figure 4 Tumour-induced neutrophil extracellular trap

Similar presentations

Ads by Google